US.ELV · Elevance Health

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 4.241475497593608,
        "turnoverUsdM": 309.78572139942,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.ELV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 344.0858,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 1,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 8.5,
      "take_profit_price": 401.4954,
      "target_multiplier": 1.6,
      "technical_strength": 1.5,
      "take_profit_percent": 6.8
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 8.482950995187217,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 50.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 46.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 4
  },
  "market": {
    "ma20": 398.1935,
    "ma50": 397.503,
    "close": 375.98,
    "prevClose": 385.73,
    "avgVolume20": 1607997,
    "volumeRatio": 0.51,
    "changePercent": -2.53
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 4,
    "details": {
      "ret_5d": -0.03369396832294802,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 4,
      "vcp_bonus": 0,
      "vol_ratio": 0.4966827215788871,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 1.0316196748547186,
      "volat_points": 0,
      "day_range_pct": 0.03444334713433307,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 50.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 76,
        "contribution": 3.8
      },
      {
        "raw": 10,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 5.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 36,
        "contribution": 5.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.9,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 59,
        "contribution": 5.9
      },
      {
        "raw": 15,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 50,
        "contribution": 15
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 46.1,
    "details": [
      "基本面分析總分: 3.8/5分",
      "資金流分析總分: 10/20分",
      "市場環境分析總分: 5.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.9/10分",
      "技術信號分析總分: 15/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.8,
      "資金流": 10,
      "市場環境": 5.4,
      "情緒分析": 4,
      "技術信號": 15,
      "風險管理": 5.9
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.5,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 309.78572139942,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.ELV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.21
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 704.3249969000001,
                "ma50": 715.8034021999999,
                "name": "QQQ",
                "close": 661.63,
                "points": 0.4
              },
              "spy": {
                "ma20": 745.7855067000002,
                "ma50": 744.6632029799998,
                "name": "SPY",
                "close": 729.46002,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 4.241475497593608,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140986403,
                "url": "https://finnhub.io/api/news?id=37779cd2aad64aa5e567d841b0513e8822db92a75af643fbc6b90b38aaf4dc2d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health has climbed 42.6% over the past year, yet the broader valuation checks still lean toward the stock looking cheap rather than stretched at current levels. The 42.6% one-year return puts Elevance Health firmly in the group of recent outperformers, raising the question of how much value is already reflected in the price. Recent earnings strength and raised earnings expectations can support the case for higher earnings power over time, while margin pressure and membership...",
                "category": "company",
                "datetime": 1784747626,
                "headline": "Elevance Health (ELV) Stock Still Looks Reasonable After A 43% Run"
              },
              {
                "id": 140921142,
                "url": "https://finnhub.io/api/news?id=3f847cc98d77910e59839c676c938ca2bda21a1b1a3b5ea6de619e5ef3cd74c3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Bernstein SocGen Group lifted its Elevance Health price target to US$482 from US$424, putting fresh attention on how analysts are reassessing the stock. Many research firms are sounding more constructive, pointing to steadier medical cost trends, support from Healthcare Services earnings, and a calmer policy backdrop, while still highlighting Medicaid and specialty drug costs as key risks. Read on to see what is driving this evolving analyst narrative and how you can keep track of the moving...",
                "category": "company",
                "datetime": 1784211266,
                "headline": "Elevance Health (ELV) Stock Sees Modest Fair Value Lift As Analysts Turn More Constructive"
              },
              {
                "id": 140916551,
                "url": "https://finnhub.io/api/news?id=efac2d318569c6b016255575c8e248860cbb3d711a6ac4f200acdc337af416b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) reported second quarter results that exceeded internal expectations. The company raised its full year guidance following the quarterly update. Management outlined plans to exit additional underperforming Medicaid markets. Elevance Health highlighted a focus on expanding Medicare Advantage and Carelon health services. Elevance Health is one of the largest U.S. managed care companies, with a broad footprint across commercial, Medicaid, Medicare Advantage, and health...",
                "category": "company",
                "datetime": 1784172258,
                "headline": "Elevance Health (ELV) Beats Q2 And Raises Outlook While Leaving More Medicaid Markets"
              },
              {
                "id": 140916144,
                "url": "https://finnhub.io/api/news?id=a989c7c07c86b9b0f96d09e010a835c10341284348a4038ba308c333ea9a4856",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CEO Boudreaux raised full-year guidance after beating Q2 projections.",
                "category": "company",
                "datetime": 1784161939,
                "headline": "Elevance Health (ELV) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140914308,
                "url": "https://finnhub.io/api/news?id=273f4e33d50f5ec90f004d1c7f689123c35ff92671cbc77e3729494240c881d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health Inc (ELV) surpasses earnings expectations, raises full-year guidance, and outlines strategic shifts in Medicaid markets.",
                "category": "company",
                "datetime": 1784149229,
                "headline": "Elevance Health Inc (ELV) Q2 2026 Earnings Call Highlights: Strong EPS Growth and Strategic ..."
              },
              {
                "id": 140912829,
                "url": "https://finnhub.io/api/news?id=24098b6ae142cdcbcbda419654be673d95009468fd3f2c82daa675ab7efa5ccf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health beats Q2 EPS and revenue estimates, raises 2026 adjusted EPS outlook despite lower earnings, softer membership and higher expenses.",
                "category": "company",
                "datetime": 1784134860,
                "headline": "ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues"
              },
              {
                "id": 140912276,
                "url": "https://finnhub.io/api/news?id=f5fa9f68445a2f150fa4376f68f7d21484c1acdb1b67ef765fc63e936c94ea35",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Elevance Health, Inc. (ELV) Q2 2026 Earnings Call July 15, 2026 8:30 AM EDTCompany ParticipantsNathan Rich - Vice President of Investor RelationsGail...",
                "category": "company",
                "datetime": 1784128077,
                "headline": "Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140909645,
                "url": "https://finnhub.io/api/news?id=4606ea1ae22a76a8d5b83635a0a0910a31388b4e568c9f13703abd9c46fca85b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Health insurance shares moved sharply lower in premarket trading after Elevance Health’s (NYSE:ELV) latest quarterly results revealed continued pressure on margins within its core Health Benefits business, raising concerns that similar challenges could affect the wider managed-care sector. Margin weakness overshadows earnings beatAlthough Elevance reported second-quarter earnings and revenue that comfortably exceeded analysts’ expectations, investors focused on the deterioration in profitability",
                "category": "company",
                "datetime": 1784122600,
                "headline": "Health insurance stocks slide after Elevance highlights margin pressures (ELV)"
              }
            ],
            "raw_source": [
              {
                "id": 141055751,
                "url": "https://finnhub.io/api/news?id=53d28f66396443a157c170dee0577554538e51740747ecca6013d4ce76ae6b32",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "HUM's Q2 earnings top estimates as medical membership growth, premium gains and CenterWell strength lift results despite higher costs.",
                "category": "company",
                "datetime": 1785338580,
                "headline": "Humana Q2 Earnings Beat Estimates on Medical Membership Growth"
              },
              {
                "id": 141056037,
                "url": "https://finnhub.io/api/news?id=2682ffddf322465597ad40a16d4e3a9cc9810d03b78dc13867efe9f06a920972",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2202778134/image_2202778134.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Delta Air Lines was a contributor during the quarter. Fuel prices spiked in March following the onset of the Iran War, creating a near-term headwind for airline profitability.",
                "category": "company",
                "datetime": 1785333720,
                "headline": "Oakmark U.S. Large Value Strategy Q2 2026 Portfolio Review"
              },
              {
                "id": 141046872,
                "url": "https://finnhub.io/api/news?id=70c6fb76e9b9d9e8714360dd25934e9a7cf62110f1342843babff8a04f79dfbd",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2148748183/image_2148748183.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Elevance Health analysis: Hold rating amid margin pressure. Click for more on ELV stock.",
                "category": "company",
                "datetime": 1785257682,
                "headline": "Elevance Health Has Upside, But Not Yet A Buy"
              },
              {
                "id": 141045238,
                "url": "https://finnhub.io/api/news?id=3139aae3364484c3face6bce1b2e8a8314412dce7906d2931a45cae10435e51a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC's Q2 earnings and revenues top estimates as stronger premium and service revenues drive results despite lower membership and higher medical costs.",
                "category": "company",
                "datetime": 1785254640,
                "headline": "Centene Q2 Earnings Beat Estimates on Increasing Premiums"
              },
              {
                "id": 141046976,
                "url": "https://finnhub.io/api/news?id=ee99550e65d283f8fc6944965013ad47621413e2f6544d5e671d18f30d079119",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "https://www.wsj.com/health/healthcare/trump-administration-to-end-medicare-drug-plan-subsidy-76d255d1",
                "category": "company",
                "datetime": 1785254534,
                "headline": "'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ Exclusive"
              },
              {
                "id": 141043824,
                "url": "https://finnhub.io/api/news?id=8c0a3b0ca16095c3b553bfe9048aea8e13a872a17e1c083525b3e78a2b94921c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) was Smart Insider's stock pick of the week after Chief Executive Gail Boudreau",
                "category": "company",
                "datetime": 1785248096,
                "headline": "Elevance Health Pick of the Week at Smart Insider Following CEO, Chairman Share Purchases"
              },
              {
                "id": 141043644,
                "url": "https://finnhub.io/api/news?id=88ec2b6c3e4ef3ac6c9a5a98ca4e20ef90022e8708fce7b5c4044ce6407b390a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UHS tops Q2 earnings and revenue estimates as Acute Care and Behavioral Health growth lifts results, even as higher costs weigh on operations.",
                "category": "company",
                "datetime": 1785245760,
                "headline": "UHS Beats Q2 Earnings and Revenue Estimates Despite Cost Pressures"
              },
              {
                "id": 141041416,
                "url": "https://finnhub.io/api/news?id=648b55f7aecaae96f9cddd2475ef973467dfa74afd833e8b4f7f6a77559d89d1",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1450625899/image_1450625899.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "U.S. Fund A Shares (without sales charge) posted a return of -0.04% in second quarter of 2026. Read more here.",
                "category": "company",
                "datetime": 1785222000,
                "headline": "First Eagle U.S. Fund Q2 2026 Portfolio Review"
              },
              {
                "id": 141037187,
                "url": "https://finnhub.io/api/news?id=e7eef0fc592a8a579ca86ba8625e22e606192746b9b9132ddb2b49647535d89e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "THC raised its 2026 outlook after Q2 earnings and revenues beat expectations, driven by strong same-facility growth and disciplined expense management.",
                "category": "company",
                "datetime": 1785179460,
                "headline": "Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook"
              },
              {
                "id": 141032445,
                "url": "https://finnhub.io/api/news?id=0aa71ebaafd6fb02da2462440c57cf4735c31be17d66640e9a3b37ac23d45d77",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2254596306/image_2254596306.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Our top performer in the second quarter was ICON plc, which gained 57%. Our largest detractor during the quarter was Intercontinental Exchange, which declined 21.7%. Read more here.",
                "category": "company",
                "datetime": 1785140760,
                "headline": "GreensKeeper Value Fund Q2 2026 Portfolio Update"
              },
              {
                "id": 141016835,
                "url": "https://finnhub.io/api/news?id=d3da66409983c7b7c0ab1e80e405394e3851f5df383fd2dec934d2fc1277ae1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Seth Klarman's Baupost Group just revealed its five largest stock positions, and the list includes a little-known industrial distributor posting explosive earnings growth alongside household names bleeding on the front page. Reverse-engineering his logic reveals a portfolio built for a very specific payoff.",
                "category": "company",
                "datetime": 1784993451,
                "headline": "Billionaire Investor Seth Klarman’s Top 5 Stocks: Would He Buy More Today?"
              },
              {
                "id": 141010762,
                "url": "https://finnhub.io/api/news?id=34cf0495c3aad32ad59c71b73880c9d0cf75062d6a008f74ecd1fff6c757b090",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.",
                "category": "company",
                "datetime": 1784926584,
                "headline": "The Real Price of UnitedHealth Stock Is Two Years Away"
              },
              {
                "id": 141007777,
                "url": "https://finnhub.io/api/news?id=ec70fca7d4366d7d7666d1585311865e707df9f66c2e2a1ea1135a70b6f4f642",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.",
                "category": "company",
                "datetime": 1784911140,
                "headline": "Can Humana Beat Q2 Earnings Estimates on Growing Premiums?"
              },
              {
                "id": 141006524,
                "url": "https://finnhub.io/api/news?id=32051c07b4e7a4e0c1418e8e01970f2ac0db8656ab65fcebe5b9d5274caa4129",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "EW beats Q2 earnings and revenue estimates as strong TAVR demand, and mitral and tricuspid therapy adoption lift results and guidance.",
                "category": "company",
                "datetime": 1784897640,
                "headline": "Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises"
              },
              {
                "id": 140994723,
                "url": "https://finnhub.io/api/news?id=79fd17c84027588375b7e5a8a236ae382385fcb274c6606fa2b953d71a8ffca8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Thermo Fisher beats Q2 earnings and revenue estimates as organic growth and stronger customer activity lift results, sending shares higher in pre-market trading.",
                "category": "company",
                "datetime": 1784815260,
                "headline": "TMO Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-Market"
              },
              {
                "id": 140987898,
                "url": "https://finnhub.io/api/news?id=2ba775d89d5d596fea078f6107eab7254cd233a690a07ce30fd544770c1dccd0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Molina healthcare has seen its stock edge down in recent days amid concerns about Medicaid cost pressures.",
                "category": "company",
                "datetime": 1784753100,
                "headline": "Molina Healthcare Earnings Beat Estimates. The Medicaid Insurer Is Confronting Investor Doubts."
              },
              {
                "id": 140986403,
                "url": "https://finnhub.io/api/news?id=37779cd2aad64aa5e567d841b0513e8822db92a75af643fbc6b90b38aaf4dc2d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health has climbed 42.6% over the past year, yet the broader valuation checks still lean toward the stock looking cheap rather than stretched at current levels. The 42.6% one-year return puts Elevance Health firmly in the group of recent outperformers, raising the question of how much value is already reflected in the price. Recent earnings strength and raised earnings expectations can support the case for higher earnings power over time, while margin pressure and membership...",
                "category": "company",
                "datetime": 1784747626,
                "headline": "Elevance Health (ELV) Stock Still Looks Reasonable After A 43% Run"
              },
              {
                "id": 140983411,
                "url": "https://finnhub.io/api/news?id=20c8f45f6c754dd551cf0b30adb0791c0967233c42d9fcfbf0a589f8e2e88922",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155443326/image_155443326.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Harris Associates’ Q1 2026 13F: portfolio fell to $75B; added CRM, ICE, KDP, ABNB, IQV; trimmed GOOGL, COP, PSX, GM. Read more macro analysis here.",
                "category": "company",
                "datetime": 1784721548,
                "headline": "Tracking William Nygren's Harris Associates Portfolio - Q1 2026 Update"
              },
              {
                "id": 140979741,
                "url": "https://finnhub.io/api/news?id=507d1f1e14f5a93c108e3a09cd93471be998753c08bb42c26fec67204e31f4e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Molina healthcare has seen its stock edge down in recent days amid concerns about Medicaid cost pressures.",
                "category": "company",
                "datetime": 1784700000,
                "headline": "This Medicaid Insurer’s Stock Has Climbed in 2026. Investors Still Have Doubts."
              },
              {
                "id": 140976384,
                "url": "https://finnhub.io/api/news?id=57236c5052f85582eb5ea0f555f013f41560f1273e2f5734bc67c62a45028091",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Investors are rightly focused on the company's Medicaid struggles, but the real upside story may be hiding in plain sight across the rest of its business.",
                "category": "company",
                "datetime": 1784669171,
                "headline": "The Hidden Engine Behind Elevance Health Stock's Next Climb"
              },
              {
                "id": 140976385,
                "url": "https://finnhub.io/api/news?id=82aea808c7ba6dd8cc4c52c74c0cbb24ac81eca4dffdd8eaae25d25ec6adcf2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth's stock is flying high after it raised guidance, but on its latest earnings call, analysts zeroed in on an underlying margin divergence running right through the business.",
                "category": "company",
                "datetime": 1784665995,
                "headline": "What Kept Coming Up When Analysts Grilled UNH"
              },
              {
                "id": 140971260,
                "url": "https://finnhub.io/api/news?id=2344fdefceebd65f91360aefc32faaadaf2f4e51f7cfcf30b5de5f02d820a46c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2253086812/image_2253086812.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Our bottom five contributors to return in Q2 were Accenture, CME Group, Salesforce, Boston Scientific and EOG Resources. Read more here.",
                "category": "company",
                "datetime": 1784633100,
                "headline": "Artisan Value Fund Q2 2026 Portfolio Update"
              },
              {
                "id": 140960646,
                "url": "https://finnhub.io/api/news?id=26611f7250ba7764b0a74ecf69e8ba7e9451005d8c6eacbd3be4626ede25f15c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The stock is trading near 52-week highs, but under the surface, commercial segment cost trends are creating headwinds.",
                "category": "company",
                "datetime": 1784558582,
                "headline": "The Real Risk Inside UnitedHealth Stock"
              },
              {
                "id": 140959652,
                "url": "https://finnhub.io/api/news?id=14bd209095618c3c03d62573372da6cc019e9e63608c356bfa1c82236a4061e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Peru's $366,050 purchase expands his direct stake to 10,908 shares, now valued at $4.03 million following the stock's 22% one-year gain.",
                "category": "company",
                "datetime": 1784553181,
                "headline": "Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now?"
              },
              {
                "id": 140958176,
                "url": "https://finnhub.io/api/news?id=a934bf20d2cc874986cd2f8a15df8e223513080fdefa35a4dc42381ad584d63d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
                "category": "company",
                "datetime": 1784540613,
                "headline": "1 Value Stock to Consider Right Now and 2 Facing Headwinds"
              },
              {
                "id": 140946978,
                "url": "https://finnhub.io/api/news?id=6948dadaeb277d2fbada05e05671d3969030c91ddc3b6dc2f4dfb085b9d1aa37",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "RSP is beating SPY for the first time in years, but two specific signals will determine whether equal-weight strategies keep their edge or surrender it back to the mega-caps before year end.",
                "category": "company",
                "datetime": 1784409063,
                "headline": "Equal-Weight Strategy RSP Could Outrun SPY if This Macro Shift Continues"
              },
              {
                "id": 140939243,
                "url": "https://finnhub.io/api/news?id=090ccd77fc25f931c05bfa56792d7943a544067073c55456310023a05aa1542b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health CEO Gail Boudreaux makes her first purchase since 2025 as shares slump after second-quarter earnings.",
                "category": "company",
                "datetime": 1784326800,
                "headline": "Elevance Health CEO Snaps Up Stock After Post-Earnings Slide"
              },
              {
                "id": 140939166,
                "url": "https://finnhub.io/api/news?id=abb851b8ee2d464a110b910c89dadec490fc80b6db6ddf24abbb5c7ae870adf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The sticker price on CVS shares looks high, but the real question is what it costs on the earnings expected two years from now.",
                "category": "company",
                "datetime": 1784326192,
                "headline": "What A Patient Holder Is Really Paying For CVS Health Stock"
              },
              {
                "id": 140939174,
                "url": "https://finnhub.io/api/news?id=50dc6e76d1c3aa89467680e6bc1cf51c7a2b8faf7bea9022ea161510d8c648b1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The health insurer raised its forecast after a solid quarter, but investors focused on the one business so broken it’s forcing a strategic retreat.",
                "category": "company",
                "datetime": 1784325720,
                "headline": "What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?"
              },
              {
                "id": 140938118,
                "url": "https://finnhub.io/api/news?id=269963ad74a61c3fbebcb5dd45d0b1c32b65bb8feda6e444a79232d571bdf298",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Boudreaux's stake now totals ~172,000 directly held shares worth $63.51 million, as Elevance maintains an $80 billion market cap and $5.0 billion in trailing net income.",
                "category": "company",
                "datetime": 1784318143,
                "headline": "Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?"
              },
              {
                "id": 140947417,
                "url": "https://finnhub.io/api/news?id=fcf0fe40ba5cfa45e0303e4c0fbfe4029cf0a94250c9c07787891e23d4c0efea",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Leerink Partners  analyst Whit Mayo   maintains Elevance Health (NYSE:ELV) with a Market Perform and raises the price target from $364 to $395.",
                "category": "company",
                "datetime": 1784297726,
                "headline": "Leerink Partners Maintains Market Perform on Elevance Health, Raises Price Target to $395"
              },
              {
                "id": 140924354,
                "url": "https://finnhub.io/api/news?id=6beff7ff98afeafc7e69e28d5375177dc8b70c8486507b5409de1426713e60de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs, sending the Dow Jones stock surging past a buy point on Thursday morning.  Rival managed-care providers including Humana, Centene and Elevance Health got a sizable lift from the initial warm reception for UnitedHealth's earnings report.  Results: UnitedHealth posted Q2 earnings per share of $6.38, up 56% from a weak year-earlier result and 30% ahead of $4.91 forecasts.",
                "category": "company",
                "datetime": 1784230057,
                "headline": "Why UNH Stock Breakout Faltered After Massive Earnings Beat"
              },
              {
                "id": 140925109,
                "url": "https://finnhub.io/api/news?id=16f6c448c54250560d5c125e305ac84062a5ec3df5730547f8f01d765763cfbf",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/540839640/image_540839640.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "UnitedHealth Group delivered a strong Q2, with improved medical care ratio and operating income up 50% YoY. Read more on UNH stock here.",
                "category": "company",
                "datetime": 1784219706,
                "headline": "UnitedHealth Group Q2: The Real Test Begins Now (Downgrade)"
              },
              {
                "id": 140921098,
                "url": "https://finnhub.io/api/news?id=3ee3e86383b3ce5a581b714972278ee2441b8d4bec1066462ce8d89a05a83334",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.",
                "category": "company",
                "datetime": 1784213644,
                "headline": "UnitedHealth stock jumps on Q2 earnings, raises full-year outlook"
              },
              {
                "id": 140920343,
                "url": "https://finnhub.io/api/news?id=9a3f747e0da7ee6cca16a7cc4b096a2b5c31412dfb8f4ffd99fea1843265e509",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Looking for the S&P500 stocks that are experiencing notable gaps on Thursday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1784212500,
                "headline": "Which S&P500 stocks are gapping on Thursday?"
              },
              {
                "id": 140921142,
                "url": "https://finnhub.io/api/news?id=3f847cc98d77910e59839c676c938ca2bda21a1b1a3b5ea6de619e5ef3cd74c3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Bernstein SocGen Group lifted its Elevance Health price target to US$482 from US$424, putting fresh attention on how analysts are reassessing the stock. Many research firms are sounding more constructive, pointing to steadier medical cost trends, support from Healthcare Services earnings, and a calmer policy backdrop, while still highlighting Medicaid and specialty drug costs as key risks. Read on to see what is driving this evolving analyst narrative and how you can keep track of the moving...",
                "category": "company",
                "datetime": 1784211266,
                "headline": "Elevance Health (ELV) Stock Sees Modest Fair Value Lift As Analysts Turn More Constructive"
              },
              {
                "id": 140923118,
                "url": "https://finnhub.io/api/news?id=849660181dbdce21c5283300d80d1ffbd4882504fe8ef32a9722935ced89a103",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/16/Konskie--Poland---September-07--2025-Uni.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.",
                "category": "company",
                "datetime": 1784208257,
                "headline": "UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses"
              },
              {
                "id": 140919761,
                "url": "https://finnhub.io/api/news?id=9e2d7a9c3858d95b05e36040d4d9fa67670edc9e6fdf517dd74ddb28b77b88f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.",
                "category": "company",
                "datetime": 1784207995,
                "headline": "The Medicaid Problem That Swallowed an Earnings Beat"
              },
              {
                "id": 140919768,
                "url": "https://finnhub.io/api/news?id=f42558d6ad029166956228b7d675af30dc5b6485d970b7e2c2615347057d3dd9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The stock is priced for strength, but a deep and persistent drag from one of its largest divisions could challenge the optimistic narrative.",
                "category": "company",
                "datetime": 1784205032,
                "headline": "The Medicaid Problem Weighing On Elevance Health Stock"
              },
              {
                "id": 140919728,
                "url": "https://finnhub.io/api/news?id=ea562688189364310e928b87698b0b1ae06ad5b160972c5e0599966669084dc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The stock's current valuation looks steep, but for a patient holder, the price tag on future earnings tells a very different story.",
                "category": "company",
                "datetime": 1784205031,
                "headline": "The Real Price of Admission for CVS Health Stock"
              },
              {
                "id": 140932081,
                "url": "https://finnhub.io/api/news?id=141e09a08599bcfa97125d1b8fa4735db766a526c1c344ebc53d0aad527d4bca",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "RBC Capital  analyst Ben Hendrix   maintains Elevance Health (NYSE:ELV) with a Sector Perform and lowers the price target from $439 to $424.",
                "category": "company",
                "datetime": 1784199784,
                "headline": "RBC Capital Maintains Sector Perform on Elevance Health, Lowers Price Target to $424"
              },
              {
                "id": 140918841,
                "url": "https://finnhub.io/api/news?id=7fc32469cbc32693e09225dbb6db0e9326b415c41557fdcf85b7c7c9d24b74f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook.  Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.",
                "category": "company",
                "datetime": 1784199650,
                "headline": "UNH Stock Flashes Buy Signal On Massive Earnings Beat"
              },
              {
                "id": 140932082,
                "url": "https://finnhub.io/api/news?id=034d6b38a3326aa8738eea0df4a2b1c343e6548f33ddfea6c64a089150a0e91c",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Wells Fargo  analyst Stephen Baxter   maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $492 to $473.",
                "category": "company",
                "datetime": 1784199154,
                "headline": "Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $473"
              },
              {
                "id": 140920429,
                "url": "https://finnhub.io/api/news?id=55a06d501bb35e7077486157269380d17e53cf4e3e10f62ab6f12c905ad44b59",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/16/Medicaid-Eligibility.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Starting in December 2026, millions of Medicaid enrollees will have to prove they still qualify twice as often as they do today, and the Urban Institute estimates the change could push 2 to 3.1 million people out of the",
                "category": "company",
                "datetime": 1784193897,
                "headline": "Medicaid's New Twice-A-Year Eligibility Check Starts In December: How To Keep Your Coverage And Which Stocks Feel It"
              },
              {
                "id": 140920430,
                "url": "https://finnhub.io/api/news?id=b8b927ceff50ebc33ed868880d7fe5344814cd454be06115b02671c661b634ef",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/16/Analysts-Debate-Depreciation-Impact.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health Inc. (NYSE:ELV) reported strong Q2 results and raised full-year guidance. Analysts have adjusted price targets for ELV stock.",
                "category": "company",
                "datetime": 1784189866,
                "headline": "These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings"
              },
              {
                "id": 140920431,
                "url": "https://finnhub.io/api/news?id=cddb642aeeab0e3e784de5ec0c446c33ee4ef5bbe10658b39ef198bc3879fd7e",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Guggenheim  analyst Jason Cassorla   maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $399 to $455.",
                "category": "company",
                "datetime": 1784188929,
                "headline": "Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $455"
              },
              {
                "id": 140920432,
                "url": "https://finnhub.io/api/news?id=ca681de8b31af5d720e6bad3a93e8e634e9b5e21a7eee694b5909fe6f26792cd",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Barclays  analyst Andrew Mok   maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $480 to $457.",
                "category": "company",
                "datetime": 1784187483,
                "headline": "Barclays Maintains Overweight on Elevance Health, Lowers Price Target to $457"
              },
              {
                "id": 140920433,
                "url": "https://finnhub.io/api/news?id=763acf2f7734b268b1a01dca8c29a05ab9608c39e75b197e9e81c80ec710e94e",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Baird  analyst Michael Ha   maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target from $331 to $393.",
                "category": "company",
                "datetime": 1784186117,
                "headline": "Baird Maintains Neutral on Elevance Health, Raises Price Target to $393"
              },
              {
                "id": 140916551,
                "url": "https://finnhub.io/api/news?id=efac2d318569c6b016255575c8e248860cbb3d711a6ac4f200acdc337af416b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) reported second quarter results that exceeded internal expectations. The company raised its full year guidance following the quarterly update. Management outlined plans to exit additional underperforming Medicaid markets. Elevance Health highlighted a focus on expanding Medicare Advantage and Carelon health services. Elevance Health is one of the largest U.S. managed care companies, with a broad footprint across commercial, Medicaid, Medicare Advantage, and health...",
                "category": "company",
                "datetime": 1784172258,
                "headline": "Elevance Health (ELV) Beats Q2 And Raises Outlook While Leaving More Medicaid Markets"
              },
              {
                "id": 140916144,
                "url": "https://finnhub.io/api/news?id=a989c7c07c86b9b0f96d09e010a835c10341284348a4038ba308c333ea9a4856",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CEO Boudreaux raised full-year guidance after beating Q2 projections.",
                "category": "company",
                "datetime": 1784161939,
                "headline": "Elevance Health (ELV) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140914308,
                "url": "https://finnhub.io/api/news?id=273f4e33d50f5ec90f004d1c7f689123c35ff92671cbc77e3729494240c881d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health Inc (ELV) surpasses earnings expectations, raises full-year guidance, and outlines strategic shifts in Medicaid markets.",
                "category": "company",
                "datetime": 1784149229,
                "headline": "Elevance Health Inc (ELV) Q2 2026 Earnings Call Highlights: Strong EPS Growth and Strategic ..."
              },
              {
                "id": 140912796,
                "url": "https://finnhub.io/api/news?id=5ccc34e4756d7738080b340739486447e99093318707e151a7d32d918ec99aee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Healthcare stocks rose late Wednesday afternoon, with the NYSE Healthcare Index adding 0.3% and the",
                "category": "company",
                "datetime": 1784144857,
                "headline": "Sector Update: Healthcare Stocks Advance Late Afternoon"
              },
              {
                "id": 140912442,
                "url": "https://finnhub.io/api/news?id=d213a7bc45e61de090c471914ad23104be342b21d7fdfd1d103000c412ff81b2",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1784142301,
                "headline": "Which S&P500 stocks are moving on Wednesday?"
              },
              {
                "id": 140912892,
                "url": "https://finnhub.io/api/news?id=0e6ad89267d2759e19053e57f5bf3ff8e94f460b4e053323259d15ac67ba77d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Pentair (PNR) reported preliminary Q2 results below market estimates and lowered its full-year outlo",
                "category": "company",
                "datetime": 1784140794,
                "headline": "Top Midday Decliners"
              },
              {
                "id": 140911280,
                "url": "https://finnhub.io/api/news?id=20b0d88f50adb6770ced929f134ea877401a5f178c1c8488b3933a62a362de03",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index adding 0.4% and the State",
                "category": "company",
                "datetime": 1784137282,
                "headline": "Sector Update: Healthcare Stocks Advance in Afternoon Trading"
              },
              {
                "id": 140912828,
                "url": "https://finnhub.io/api/news?id=6a2f695c5eae9d2ff3253e3f2e31d9dc4dc2af33a6ad9533d31fa8e361552a22",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health beat estimates for earnings and medical cost ratio, but that wasn’t enough to outweigh concerns about high Medicaid spending.",
                "category": "company",
                "datetime": 1784137140,
                "headline": "Elevance Beat Earnings Estimates, but the Stock Falls on Medicaid Spending Worries"
              },
              {
                "id": 140912829,
                "url": "https://finnhub.io/api/news?id=24098b6ae142cdcbcbda419654be673d95009468fd3f2c82daa675ab7efa5ccf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health beats Q2 EPS and revenue estimates, raises 2026 adjusted EPS outlook despite lower earnings, softer membership and higher expenses.",
                "category": "company",
                "datetime": 1784134860,
                "headline": "ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues"
              },
              {
                "id": 140909590,
                "url": "https://finnhub.io/api/news?id=88fcc255731ec69886d1295814f3e784ca3de4fa2badc7f414c8666b92de4cbb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "All three major US stock indexes were up in late-morning trading Wednesday, as technology stocks led",
                "category": "company",
                "datetime": 1784130649,
                "headline": "Top Midday Stories: PayPal Reportedly Gets Acquisition Offer From Stripe, Advent; ASML Misses Q2 EPS, Sales Estimates, Lifts Outlook"
              },
              {
                "id": 140909826,
                "url": "https://finnhub.io/api/news?id=20da16dff8f4ee93a9cd7e4e98106f5f4ee15994ed5fcead903784018504458b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) reported sequential and annual declines in its second-quarter memberships, alt",
                "category": "company",
                "datetime": 1784130131,
                "headline": "Elevance Second-Quarter Membership Declines Overshadow Full-Year Earnings Outlook Raise"
              },
              {
                "id": 140912276,
                "url": "https://finnhub.io/api/news?id=f5fa9f68445a2f150fa4376f68f7d21484c1acdb1b67ef765fc63e936c94ea35",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Elevance Health, Inc. (ELV) Q2 2026 Earnings Call July 15, 2026 8:30 AM EDTCompany ParticipantsNathan Rich - Vice President of Investor RelationsGail...",
                "category": "company",
                "datetime": 1784128077,
                "headline": "Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 140909827,
                "url": "https://finnhub.io/api/news?id=eb958ec4e88f2c60d2f5717f601b0e32e2769fad6c0bcb173fca116f6632220d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) raised its 2026 adjusted earnings outlook after second-quarter results came in ahead of management’s expectations, citing favorable benefit expense performance, disciplined cost management and improving execution across several major business lines. President and CEO Gail",
                "category": "company",
                "datetime": 1784127851,
                "headline": "Elevance Health Q2 Earnings Call Highlights"
              },
              {
                "id": 140908982,
                "url": "https://finnhub.io/api/news?id=1b7789559689abb11ca6cbcb9adc84b382becc569522872471f7d746dfe9f4f9",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1784126101,
                "headline": "Which S&P500 stocks are gapping on Wednesday?"
              },
              {
                "id": 140909645,
                "url": "https://finnhub.io/api/news?id=4606ea1ae22a76a8d5b83635a0a0910a31388b4e568c9f13703abd9c46fca85b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Health insurance shares moved sharply lower in premarket trading after Elevance Health’s (NYSE:ELV) latest quarterly results revealed continued pressure on margins within its core Health Benefits business, raising concerns that similar challenges could affect the wider managed-care sector. Margin weakness overshadows earnings beatAlthough Elevance reported second-quarter earnings and revenue that comfortably exceeded analysts’ expectations, investors focused on the deterioration in profitability",
                "category": "company",
                "datetime": 1784122600,
                "headline": "Health insurance stocks slide after Elevance highlights margin pressures (ELV)"
              },
              {
                "id": 140909829,
                "url": "https://finnhub.io/api/news?id=b386fc5c25ddd6c833729bdc4c3495e4c7fb90d653e1494e977a5d6e0484f61a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1784122203,
                "headline": "Compared to Estimates, Elevance Health (ELV) Q2 Earnings: A Look at Key Metrics"
              },
              {
                "id": 140908293,
                "url": "https://finnhub.io/api/news?id=014143566dd956f87b5cfb8a7e696dd83c5c707a6bddb5331028a8f104205274",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health topped Q2 earnings estimates Wednesday, despite falling medical membership, but profit was boosted by one-time \"below-the-line\" factors and the full-year outlook was underwhelming.  ELV stock tumbled, making it among the S&P 500's early laggards.  Molina Healthcare, another S&P 500 managed care stock, joined Elevance among the biggest laggards performers in pre-market trading.",
                "category": "company",
                "datetime": 1784120190,
                "headline": "Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next"
              },
              {
                "id": 140907857,
                "url": "https://finnhub.io/api/news?id=c6c9fadccd35ba1fed87eb33657c5d3e74fc3bd0010caa0c3e6a9e822474a0f5",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.",
                "category": "company",
                "datetime": 1784118901,
                "headline": "Get insights into the top movers in the S&P500 index of Wednesday's pre-market session."
              },
              {
                "id": 140908474,
                "url": "https://finnhub.io/api/news?id=eb6ed150a13b54588022c63a385bbf198b54a240c9af9aa465bee94be8e03ad2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) reported stronger-than-expected second-quarter earnings and raised its full-year outlook, but the health insurer’s shares fell more than 9 percent in premarket trading as investors focused on declining profit margins. Earnings and revenue surpass expectationsThe company posted adjusted earnings per share of 7.",
                "category": "company",
                "datetime": 1784118555,
                "headline": "Elevance Health beats second-quarter forecasts but shares slide on margin pressure (ELV)"
              },
              {
                "id": 140910359,
                "url": "https://finnhub.io/api/news?id=0244e374934474222a73a8a67c7324257918da769a2d07d899fe826d397a8f6b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "We believe the airline industry will emerge from the recent fuel price shock with improved profitability and see Delta as especially well positioned.",
                "category": "company",
                "datetime": 1784117880,
                "headline": "Oakmark Fund Q2 2026 Portfolio Activity"
              },
              {
                "id": 140907461,
                "url": "https://finnhub.io/api/news?id=d9e07d894e9e87b569ae71b67f25b242f8405d36966fddfe8c414ae2975ec6b2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Investing.com -- Elevance Health’s Health Benefits operating profit collapsed in the second quarter of 2026, igniting a broad premarket selloff across the managed-care sector even as the insurer’s headline earnings handily beat estimates and full-year guidance was lifted.",
                "category": "company",
                "datetime": 1784114481,
                "headline": "Insurance stocks fall after Elevance Health results show margin pressure"
              },
              {
                "id": 140907213,
                "url": "https://finnhub.io/api/news?id=97ca777b723a18aca7cffd182eb222ab1bb4aa76206a145847301adb20966af9",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_17_c249efcc18.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Elevance Health reported strong Q2 2026 earnings with an EPS beat of $7.45, but shares fell 7.4% pre-market due to rising medical costs and compressed margins.",
                "category": "company",
                "datetime": 1784114454,
                "headline": "Elevance Health (NYSE:ELV) Earnings Beat and Raised Guidance Overshadowed by Margin Pressure"
              },
              {
                "id": 140908475,
                "url": "https://finnhub.io/api/news?id=ac2ed6afd364d874f2e12a889fd1345ccf9970270f979dde48cca7913ef35fe9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) delivered earnings and revenue surprises of +20.55% and +2.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1784113801,
                "headline": "Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates"
              },
              {
                "id": 140907541,
                "url": "https://finnhub.io/api/news?id=dfc969689fd763520c150e16c11a9279519ed1f74d04cdb15ec5cdacacebe821",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Investing.com -- Elevance Health Inc. (NYSE: ELV) reported second-quarter results that exceeded analyst expectations, though shares are down more than 9% premarket as investors focused on margin concerns.",
                "category": "company",
                "datetime": 1784112484,
                "headline": "Elevance Health beats estimates but shares tumble as margins drop"
              },
              {
                "id": 140909300,
                "url": "https://finnhub.io/api/news?id=ff6c5b35f45b2e3bfa44627d1809be8568adf47b6f492f2b6559b36fc9784354",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/15/Elevance-Health-Photo-by-Jonathan-Weiss-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a conservative guidance raise.",
                "category": "company",
                "datetime": 1784110953,
                "headline": "Elevance Health's Small Outlook Boost Disappoints, Stock Sinks"
              },
              {
                "id": 140907542,
                "url": "https://finnhub.io/api/news?id=7f2db0842dc6ba3ab895f9d503c754b4aee7be4237a695eb8969b46ac9cbac92",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Health insurance provider Elevance Health (NYSE:ELV) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 2.1% year on year to $50.47 billion. Its non-GAAP profit of $7.45 per share was 20% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1784110492,
                "headline": "Elevance Health (NYSE:ELV) Reports Bullish Q2 CY2026"
              },
              {
                "id": 140907462,
                "url": "https://finnhub.io/api/news?id=9631ad0cc7263169e471ef76e3d4b0799bcd068c0327d63754bef75ca655818c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health  stock rose in premarket trading Wednesday after the health insurer handily cleared analysts’ earnings estimates and boosted its full-year outlook for the second time in months.  For the second quarter, the health insurer posted adjusted earnings of $7.45 a share on revenue of $49.8 billion.  Wall Street was looking for profit of $6.21 and revenue of $48.8 billion.",
                "category": "company",
                "datetime": 1784110260,
                "headline": "Elevance Beats Earnings Estimates and There’s Even More Lifting the Stock"
              },
              {
                "id": 140911459,
                "url": "https://finnhub.io/api/news?id=cd61a299894d38a3a408783831881a6066152b8770030fb8658807daa8054902",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance will leave D.C. this summer and is considering other markets to depart, executives said. The company outperformed Wall Street expectations in the second quarter — but not by much, and its stock fell accordingly.",
                "category": "company",
                "datetime": 1784109600,
                "headline": "Elevance shuts down D.C. Medicaid business, eyes additional exits after passable Q2"
              },
              {
                "id": 140907544,
                "url": "https://finnhub.io/api/news?id=28d71b005f0a1d171291eaa6df4f92273a99f51c50dce4b001658bebd9601423",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "INDIANAPOLIS, July 15, 2026--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2026 results ahead of expectations.",
                "category": "company",
                "datetime": 1784109600,
                "headline": "Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance"
              },
              {
                "id": 140908789,
                "url": "https://finnhub.io/api/news?id=e37ac3a2f695d8b21c987bc3b0604dc32041460c9b1d20dcf0b4808992ce3df5",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/15/Display-Of-Stock-Market-Quotes.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "US stock futures mostly higher, Nasdaq up by 100 points. Phoenix Education falls after cutting sales guidance. Other stocks also down in pre-market.",
                "category": "company",
                "datetime": 1784102535,
                "headline": "Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session"
              },
              {
                "id": 140910786,
                "url": "https://finnhub.io/api/news?id=c4a2d146e21fb7daa47e67c402fb3a6be0643ebcff00aa0e2b61cce8bc1a91ef",
                "image": "https://image.cnbcfm.com/api/v1/image/108260658-17701229642026-02-03t122144z_241610661_rc2bejauv8r4_rtrmadp_0_paypal-results.jpeg?v=1770122981&w=1920&h=1080",
                "source": "CNBC",
                "related": "ELV",
                "summary": "These are the stocks posting the largest moves premarket.",
                "category": "company",
                "datetime": 1784100829,
                "headline": "Stocks making the biggest moves premarket: BlackRock, PayPal, ASML, Morgan Stanley & more"
              },
              {
                "id": 140908853,
                "url": "https://finnhub.io/api/news?id=89e4833a9fa20ccd77cb554da88c61423a07541323a70d40a9fcab10af32f087",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/earnings_scheduled_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Companies Reporting Before The Bell\n• VCI Global (NASDAQ:VCIG) is estimated to report earnings for its Fiscal Year 2025. \n• PNC Financial Services Gr (NYSE:PNC) is projected to report quarterly earnings at $4.43 per",
                "category": "company",
                "datetime": 1784099470,
                "headline": "Earnings Scheduled For July 15, 2026"
              },
              {
                "id": 140909303,
                "url": "https://finnhub.io/api/news?id=00f0149df9d01c049a51740b1e3596d9d7ea24e27d6122b13e387a5ed0b5aadd",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) FY2026 EPS expected to be more than $20.10 vs $20.26 Est..",
                "category": "company",
                "datetime": 1784095324,
                "headline": "Elevance Health Sees FY2026  GAAP EPS expected to be more than $20.10 vs $20.26 Est"
              },
              {
                "id": 140909304,
                "url": "https://finnhub.io/api/news?id=597f71da914b3dec6a4e0400cc9fc5f73c1d8c62672f7e7a1d75f6c7fbdde0ff",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est..",
                "category": "company",
                "datetime": 1784095298,
                "headline": "Elevance Health Sees FY2026  Adj EPS expected to be more than $27.00 vs $26.91 Est"
              },
              {
                "id": 140909305,
                "url": "https://finnhub.io/api/news?id=4c9f12f5128b30c50ce041f14024254a8cdd3085bc02789b60ab3058ebe71948",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) reported quarterly earnings of $7.45 per share which beat the analyst consensus estimate of $6.21 by 19.97 percent. This is a 15.72 percent decrease over earnings of $8.84 per share from the",
                "category": "company",
                "datetime": 1784095275,
                "headline": "Elevance Health Q2 Adj. EPS $7.45 Beats $6.21 Estimate, Sales $49.826B Beat $48.693B Estimate"
              },
              {
                "id": 140904230,
                "url": "https://finnhub.io/api/news?id=607e502f4f3fe6b5cee10336f7830f10eeab071ebb3f035eef6e4db481b74e11",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health  is breaking the Medicare Advantage curse, and the insurer’s earnings could show it on Wednesday.  Health insurer stocks have rallied this year after a tough run of rising medical costs that hampered earnings in 2024 and 2025.  The results come just a day ahead of the monster of the industry,  UnitedHealth Group  Wall Street will be watching to see if these two companies can keep the momentum going.",
                "category": "company",
                "datetime": 1784066820,
                "headline": "Elevance Is Overcoming Medicare Advantage Hurdles. Earnings Could Show It."
              },
              {
                "id": 140899782,
                "url": "https://finnhub.io/api/news?id=9be81e76290c8d226d316b64cd63a300c084d3e417dd3b3b786f3221a0c3cee2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC stock's 66% rally reflects improving margins, stronger cash flow and renewed earnings growth, but can the turnaround keep gaining momentum?",
                "category": "company",
                "datetime": 1784047560,
                "headline": "Centene Stock Soars 66% YTD: Should Investors Chase the Rally?"
              },
              {
                "id": 140898315,
                "url": "https://finnhub.io/api/news?id=94d306fee147d34fdaef6bd06be4ab74d023956ff65929a7430d568ab1323dd3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Harris Oakmark recently released its second-quarter 2026 investor letter for the “Oakmark Equity and Income Fund”. A copy of the letter can be downloaded here. Oakmark Equity and Income Fund aims to maximize returns while preserving and enhancing capital. The portfolio consists of US equities and fixed-income securities. The allocation was 60.1% in equities, 38.9% […]",
                "category": "company",
                "datetime": 1784037355,
                "headline": "Will the Market Recognize the True Potential of Elevance Health (ELV)?"
              },
              {
                "id": 140901853,
                "url": "https://finnhub.io/api/news?id=08d571c968f57336977aab59a1cca4654613807e72a8ec6b714935441c712876",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "TD Cowen  analyst Ryan Langston   maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $400 to $465.",
                "category": "company",
                "datetime": 1784028424,
                "headline": "TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $465"
              },
              {
                "id": 140901854,
                "url": "https://finnhub.io/api/news?id=00b16242f2f0d9fe7d4e33d86dc32dc4fe12a55a4dc11b5214d6885ea70941dd",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Truist Securities  analyst David Macdonald   maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $450 to $475.",
                "category": "company",
                "datetime": 1784021467,
                "headline": "Truist Securities Maintains Buy on Elevance Health, Raises Price Target to $475"
              },
              {
                "id": 140893809,
                "url": "https://finnhub.io/api/news?id=5c39ad61add480459273143876483fdbd64477096008dc8f02862c9302e9b01a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Health insurance provider Elevance Health (NYSE:ELV) will be reporting results this Wednesday before market hours. Here’s what to look for.",
                "category": "company",
                "datetime": 1784000935,
                "headline": "Elevance Health (ELV) Q2 Earnings Report Preview: What To Look For"
              },
              {
                "id": 140890118,
                "url": "https://finnhub.io/api/news?id=2d67f1cbe12d9df8211cfc8bae473d12b523f08edb98312468848a3f2b0237d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "ELV faces Q2 pressure as weaker Health Benefits results and higher benefit expenses may weigh on earnings ahead of its July 15 report.",
                "category": "company",
                "datetime": 1783966080,
                "headline": "Will Health Benefits Weakness Drag Elevance's Q2 Earnings?"
              },
              {
                "id": 140890002,
                "url": "https://finnhub.io/api/news?id=d8c2e200c9611f9b0e535a383ec14dcf3c85fa8c298a7875df83cf79809fe853",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The health care giant commands a premium price over its rivals, but its core numbers tell a different story. Is the market seeing a future that isn't in the results yet.",
                "category": "company",
                "datetime": 1783965262,
                "headline": "The Premium On CVS Stock Vs What Its Peers Deliver"
              },
              {
                "id": 140890413,
                "url": "https://finnhub.io/api/news?id=3b91d93c66065873ed3ce831f3f4939ea4d265123d99d604450a70f954fda6df",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Wells Fargo  analyst Stephen Baxter   maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $391 to $492.",
                "category": "company",
                "datetime": 1783937847,
                "headline": "Wells Fargo Maintains Overweight on Elevance Health, Raises Price Target to $492"
              },
              {
                "id": 140884411,
                "url": "https://finnhub.io/api/news?id=b4219694bcd52c04d319364a773c63e6a86eec98d629f5b513ea0832778792d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "After a rocky start to the year, health insurer stocks have roared back.  The insurers are trying to end a difficult cycle that began about three years ago, when healthcare use, and the costs to cover it, accelerated postpandemic.  The fund’s top 10 holdings encompass six health insurers, three of which—  UnitedHealth Group  Aetna parent  CVS Health  and  Elevance Health  —comprise more than 40% of the fund.",
                "category": "company",
                "datetime": 1783926000,
                "headline": "Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks"
              },
              {
                "id": 140870748,
                "url": "https://finnhub.io/api/news?id=4f0db8339ea47627e27c6b736482771e4d4822969b493892167865fe80847118",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2249460798/image_2249460798.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Elevance Health analysis: why the stock looks undervalued despite risks, with steady growth and insurance tailwinds. Click to get the upside case now.",
                "category": "company",
                "datetime": 1783759500,
                "headline": "Elevance Health: Defense For An Undervalued Price"
              },
              {
                "id": 140867604,
                "url": "https://finnhub.io/api/news?id=b2c456b47733e0e5024f3638fb6274cb3e6364a96604ef0131c01ad01f4d783e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Recent analyst forecasts pointing to lower quarterly earnings of $6.18 per share and decreasing revenue expectations have put Elevance Health (ELV) in focus. Investors are reassessing the stock after these projections surfaced. See our latest analysis for Elevance Health. Despite the cautious earnings outlook, Elevance Health’s share price has climbed 33.61% over the past 90 days and delivered a 24.75% total shareholder return over the last year, suggesting recent momentum remains firmly...",
                "category": "company",
                "datetime": 1783729099,
                "headline": "Elevance Health (ELV) Could Be Fully Valued After Lower Earnings And Revenue Forecasts"
              },
              {
                "id": 140866980,
                "url": "https://finnhub.io/api/news?id=690eb3d41bfd77ba7ccf9dae06dec1cadcc53fdf01e95d81b0c66017033b6048",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "In late June 2026, Elevance Health, Inc. was removed from the Russell 1000 Value-Defensive and Russell 1000 Defensive indexes but added to the Russell 1000 Dynamic Index, while analysts projected a year-over-year earnings and revenue decline for the upcoming quarter. This combination of index reclassification and a weaker earnings outlook highlights how investors are reassessing Elevance Health’s risk profile and operational resilience within the health benefits space. With analysts...",
                "category": "company",
                "datetime": 1783725234,
                "headline": "Should Elevance Health’s (ELV) Index Shift and Softer Outlook Require Action From Investors?"
              },
              {
                "id": 140864271,
                "url": "https://finnhub.io/api/news?id=2e1f4d2e2bd8a771190b14a8e47325fa8f08b3d3b73ff3f485a97a763923bec7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health's disciplined capital allocation, strong cash generation and continued investments in Carelon and AI support long-term growth while rewarding shareholders.",
                "category": "company",
                "datetime": 1783700700,
                "headline": "Is ELV's Capital Allocation Strategy Creating Long-Term Value?"
              },
              {
                "id": 140864272,
                "url": "https://finnhub.io/api/news?id=8cb9ceee7f486eaba0b4c7d9e75a7a6713c50af11938b8057df4ec2e73f044c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth launches a Lifestyle Spending Account through UHC Store, expanding flexible wellness benefits and simplifying employer administration with digital integration.",
                "category": "company",
                "datetime": 1783700580,
                "headline": "Can UNH's Lifestyle Spending Account Redefine Employee Benefits?"
              },
              {
                "id": 140863107,
                "url": "https://finnhub.io/api/news?id=f9ca5d1fb3849a5741e3aa3ad0fa3c3db0a256ff19b897052aa1fa6dcb6a406e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Beyond analysts' top-and-bottom-line estimates for Elevance Health (ELV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.",
                "category": "company",
                "datetime": 1783689306,
                "headline": "Curious about Elevance Health (ELV) Q2 Performance? Explore Wall Street Estimates for Key Metrics"
              },
              {
                "id": 140861604,
                "url": "https://finnhub.io/api/news?id=61a62b28568787b7d6c7c35482b3faf80155aede3728d9b5b2daab140f8f391b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.",
                "category": "company",
                "datetime": 1783684540,
                "headline": "UNH Showered Owners With Cash. The Stock Did Not Cooperate"
              },
              {
                "id": 140860584,
                "url": "https://finnhub.io/api/news?id=b0b89f578c00f4ef5ee36881a23109c43fd7c57d2231e57e1adfbc28747b77a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of UNH last traded around $430.72 on July 9, sitting on a more than 28% year-to-date gain and a more than 42% one-year return. The repricing thesis showed ... The Main Reason Behind Buying UnitedHealth Before July 16",
                "category": "company",
                "datetime": 1783683039,
                "headline": "The Main Reason Behind Buying UnitedHealth Before July 16"
              },
              {
                "id": 140854824,
                "url": "https://finnhub.io/api/news?id=3770fd59125227984b77c2272111f893c4e87f667f2c3ea93af4cc921752ce83",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "U.S.-Iran tensions likely to lift demand for defensive plays, with Tenet Healthcare, Elevance Health and Aveanna Healthcare standing out as cheap medical stocks.",
                "category": "company",
                "datetime": 1783621320,
                "headline": "3 Cheap Medical Stocks to Buy as US-Iran Tensions Keep Markets on Edge"
              },
              {
                "id": 140851085,
                "url": "https://finnhub.io/api/news?id=8adf9b348f35c0c0a3be660407ce5ea98e1ef6c1e2ba39157ca6bd62925c0963",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.",
                "category": "company",
                "datetime": 1783604827,
                "headline": "The Real Price of UnitedHealth Stock Isn't on Today's Label"
              },
              {
                "id": 140862250,
                "url": "https://finnhub.io/api/news?id=47c5f1fb24acc97f4f74b8414a0af6507e12d5578aa707e9e2d969a4e868a811",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "RBC Capital  analyst Ben Hendrix   maintains Elevance Health (NYSE:ELV) with a Sector Perform and raises the price target from $358 to $439.",
                "category": "company",
                "datetime": 1783603701,
                "headline": "RBC Capital Maintains Sector Perform on Elevance Health, Raises Price Target to $439"
              },
              {
                "id": 140852319,
                "url": "https://finnhub.io/api/news?id=02313953909cfd5bd5c305ce332838316433cfbae6e608d396d6092aa452bddc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC is turning operational improvements into margin gains, with stronger cost controls and AI-driven tools supporting profitability. Can the momentum continue?",
                "category": "company",
                "datetime": 1783603560,
                "headline": "Can Centene's Operational Execution Keep Margin Recovery on Track?"
              },
              {
                "id": 140841884,
                "url": "https://finnhub.io/api/news?id=50e5a1c78ddebeb77529b4f62119969cc4e188752fcf53a06195468e42ba8c26",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1783519204,
                "headline": "Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for"
              },
              {
                "id": 140838999,
                "url": "https://finnhub.io/api/news?id=5353269331d21e63bf3e1e00d44e31da4f543ea02de5ed898b7009f5b7c96087",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.",
                "category": "company",
                "datetime": 1783501124,
                "headline": "1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off"
              },
              {
                "id": 140842224,
                "url": "https://finnhub.io/api/news?id=6dad94e862ff6c190e959322238a1c9d4daa0bc3fb2243a5e341f753470ebe88",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "https://www.wsj.com/health/healthcare/obamacare-insurers-seek-big-rate-hikes-again-8a4bf9e4",
                "category": "company",
                "datetime": 1783493535,
                "headline": "Reported Earlier, 'Obamacare Insurers Seek Big Rate Hikes, Again' - WSJ Exclusive"
              },
              {
                "id": 140833664,
                "url": "https://finnhub.io/api/news?id=d52adb508224a59195fb2dae12a3ff77cf6f6cd8b73539188df2a74d32f1141c",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Cantor Fitzgerald  analyst Sarah James   maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $400 to $450.",
                "category": "company",
                "datetime": 1783410910,
                "headline": "Cantor Fitzgerald Maintains Overweight on Elevance Health, Raises Price Target to $450"
              },
              {
                "id": 140824512,
                "url": "https://finnhub.io/api/news?id=08edb5cff4600df08617348861fdf55c8573c4941d321e298a8a37d3d04b1753",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "INDIANAPOLIS, July 06, 2026--Elevance Health (NYSE: ELV) will release second quarter 2026 financial results on July 15, 2026, at 6:00 a.m. Eastern Daylight Time (\"EDT\"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:",
                "category": "company",
                "datetime": 1783369800,
                "headline": "Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026"
              },
              {
                "id": 140823607,
                "url": "https://finnhub.io/api/news?id=9ecdfd2b0f6da36265db45401372341df403da357b0b2d9770ad82815fcc901e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth is prioritizing profitability over rapid growth as improving margins, stronger earnings and Optum expansion aim to support a long-term turnaround.",
                "category": "company",
                "datetime": 1783363020,
                "headline": "UnitedHealth Bets on Profitability Over Growth: Will It Pay Off?"
              },
              {
                "id": 140822476,
                "url": "https://finnhub.io/api/news?id=b2e1e49bb197b35eec46ff2d4eabbd1813696e1a0e58ef55d262ac5fd33d825b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.",
                "category": "company",
                "datetime": 1783354301,
                "headline": "What CVS Health Stock Was Telling You About Its Three-Dollar Earnings Prize"
              },
              {
                "id": 140821071,
                "url": "https://finnhub.io/api/news?id=592273d19e22985cad46f80bc5116eadc56b7a0b3cc7b425a713e3fb06c4ef27",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC expands AI-driven fraud prevention and payment integrity to improve Medicaid margins, boost cost controls and support long-term earnings growth.",
                "category": "company",
                "datetime": 1783347120,
                "headline": "Can Centene's Fraud Prevention Strategy Support Margin Recovery?"
              },
              {
                "id": 140822721,
                "url": "https://finnhub.io/api/news?id=7c34012c89403715ebce6aac9eeeb7b998f184997cfe195a8508b7a93f4dbcb7",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/06/Judge-Gavel--Scales-Of-Justice-And-Law-B.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance sued HHS and CMS, alleging unequal Medicare Star Ratings treatment cost it about $115 million in 2027 bonus payments.",
                "category": "company",
                "datetime": 1783332151,
                "headline": "Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit"
              },
              {
                "id": 140803774,
                "url": "https://finnhub.io/api/news?id=380385059deeff3b043022228fda3e2472a6d5621d5266748bcdc2c2d67bc049",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) has filed a lawsuit against the Centers for Medicare & Medicaid Services over how Medicare Advantage star ratings were recalculated. The company argues CMS used different processes for Elevance compared with Clover Health, which it says led to a substantial loss of bonus payments. The dispute centers on regulatory consistency and could influence how quality scores and related payments are handled for Medicare insurers. For investors tracking Elevance Health, the...",
                "category": "company",
                "datetime": 1783120241,
                "headline": "Elevance Health (ELV) Sues CMS Over Medicare Ratings And Lost Bonus Payments"
              },
              {
                "id": 140801175,
                "url": "https://finnhub.io/api/news?id=8b7124b92d3efc1f80085b44a17999b038ee6a12551b725d91dde378bc2cf37d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "After a solid 22.7% 1 year return, Elevance Health is trading with valuation checks that still lean supportive. The question for investors is whether the recent share price strength has already captured most of the upside or not. Over the past year, Elevance Health has returned 22.7%, which puts recent gains front and center when judging how much value may be left on the table. On the fundamentals side, ongoing investments in platforms like Health OS can support earnings power, while...",
                "category": "company",
                "datetime": 1783095068,
                "headline": "Can Elevance Health (ELV) Stay Below Fair Value After A 23% Gain?"
              },
              {
                "id": 140800079,
                "url": "https://finnhub.io/api/news?id=2f5fc42a6d8959c9d44f58caaa9f95b1a0e7e174e1bd7d24eac16aad773015a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "ELV seeks to recover an estimated $115 million through a CMS lawsuit over Medicare Advantage Star Ratings and disputed bonus payments.",
                "category": "company",
                "datetime": 1783087980,
                "headline": "Can Elevance Recover $115 Million Through Its CMS Lawsuit?"
              },
              {
                "id": 140799596,
                "url": "https://finnhub.io/api/news?id=9d7c8a74781110e0586d2075b0302a1ab12db07b4d4c615d7893097542bb990e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.",
                "category": "company",
                "datetime": 1783081253,
                "headline": "The Unpopular Move That Telegraphed the Elevance Health Stock Surge"
              },
              {
                "id": 140794056,
                "url": "https://finnhub.io/api/news?id=b8d3fb1bb6c59c2cee93b5acc24394bc2832a9c2130be0971213ac58e3c16622",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Cigna's Evernorth launched AI-powered Pharmacy Forward to speed up specialty prescriptions, cut delays and boost efficiency with a $100M investment.",
                "category": "company",
                "datetime": 1783015800,
                "headline": "Cigna Brings AI to Specialty Pharmacy With Pharmacy Forward"
              },
              {
                "id": 140793011,
                "url": "https://finnhub.io/api/news?id=27db7288257cdca8c9e42bc618789c425a2e6b040cc94164cc45db55fec4a919",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC's integrated healthcare model, AI-driven operations and improving Medicaid margins are strengthening earnings as the company raises 2026 EPS guidance.",
                "category": "company",
                "datetime": 1783004280,
                "headline": "Can Centene's Integrated Healthcare Model Support Earnings Growth?"
              },
              {
                "id": 140795075,
                "url": "https://finnhub.io/api/news?id=f91606a60a7d889106ec375f1534e764f971781f7bd1a4dd42685ee6a2d0fb9c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Regulators recalculated plans’ quality scores last month after losing a lawsuit to Clover Health. But they used a different methodology for Clover than its peers, causing Elevance to lose out on $115 million, the insurer told a court.",
                "category": "company",
                "datetime": 1783003585,
                "headline": "Elevance sues CMS after Medicare Advantage stars recalculation"
              },
              {
                "id": 140778856,
                "url": "https://finnhub.io/api/news?id=c19cfc1e985c5a53cebfeb6e4429da38ef0c06dac153e4c11a41468bd7f8107a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health Inc. (NYSE:ELV) is one of the best value stocks to buy right now. On June 23, Elevance Health announced enhancements to Health OS, a secure platform that streamlines clinical reviews by integrating directly with electronic health records. By replacing manual processes with automated data sharing, the system significantly reduces administrative burdens for providers, […]",
                "category": "company",
                "datetime": 1782901424,
                "headline": "Elevance Health (ELV) Enhances Health OS to Automate Clinical Reviews and Reduce Provider Administrative Burdens"
              },
              {
                "id": 140772084,
                "url": "https://finnhub.io/api/news?id=4c7a0263fc2d1a54da8e95d1afa6b55ce1dff0ad083f6997d219b70da86da860",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Company confirms name change and reaffirms 2026 objectivesPlus Therapeutics, Inc. (NASDAQ:PSTV), a healthcare company focused on central nervous system cancers, announced it will rebrand as Cerenome and begin trading on the Nasdaq under the new ticker symbol CNSY on August 3, 2026.",
                "category": "company",
                "datetime": 1782823788,
                "headline": "Plus Therapeutics to rebrand as Cerenome and adopt CNSY ticker on August 3 (PSTV)"
              },
              {
                "id": 140762687,
                "url": "https://finnhub.io/api/news?id=a36ea2f5e2fae0cf60e0025d99c9244f4547e98020eff491c6a8748cacb71939",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6.8%. The stock now trades at $395.55, marking a 13.5% gain. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1782747975,
                "headline": "2 Reasons to Like ELV (and 1 Not So Much)"
              },
              {
                "id": 140762586,
                "url": "https://finnhub.io/api/news?id=5f2b4b890c02b3b19fefd016ce954d30cd50e96a8b966ca74f28806373f43558",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.",
                "category": "company",
                "datetime": 1782744240,
                "headline": "How CenterWell Is Driving Humana's Growth Beyond Insurance"
              },
              {
                "id": 140761679,
                "url": "https://finnhub.io/api/news?id=ddf543ce8a0cf2d79bba541d31ab2d29aadc60a1d7619c881d6da089190052c0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Heartland Advisors, an investment management company, released its first-quarter 2026 investor letter for the “Heartland Opportunistic Value Equity Strategy”. A copy of the letter can be downloaded here. Improving market breadth was noted in the first quarter, but geopolitical instability in the Middle East disrupted this trend. Instead of speculating on the conflict’s duration or […]",
                "category": "company",
                "datetime": 1782740542,
                "headline": "Elevance Health (ELV) Fell Amid Healthcare Sector Downturn"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 126,
            "discarded_article_count": 101
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 15,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.1,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.1,
            "vcp_reason": "跌縮量(近10日3日)；升放量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 1690386.6666666667,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 1813860,
              "avg_vol_20": 1658890,
              "avg_vol_30": 1690386.6666666667,
              "range_pct_10": 0.08795674535994612,
              "range_pct_20": 0.19485073155884003,
              "range_pct_30": 0.19485073155884003,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.0730444316487746,
              "dist_to_20d_high": 0.1381349288954458,
              "down_shrink_days": 3,
              "breakout_level_20d": 436.23999,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.4514057743395507
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 1.6,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 4.241475497593608,
              "turnoverUsdM": 309.78572139942,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.ELV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 344.0858,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 1,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 8.5,
            "take_profit_price": 401.4954,
            "target_multiplier": 1.6,
            "technical_strength": 1.5,
            "take_profit_percent": 6.8
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 8.482950995187217,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 15.9471,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 4.24
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -65.28
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.014
    },
    "kdj": {
      "d": 37.5,
      "j": 51.09,
      "k": 42.03,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 45.71
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 11192658,
      "recentSlope": 391035.8,
      "previousSlope": -318900
    },
    "rsi": 31.92,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 405.1941,
      "position": "SAR喺價上",
      "distancePct": 7.77,
      "previousTrend": "下降"
    },
    "ma50": 397.503,
    "macd": {
      "macd": -5.810109282865994,
      "trend": "看跌",
      "signal": -3.332220400627743,
      "histogram": -2.4778888822382514
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 396.7391,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.51,
      "score": 2,
      "avgVolume": 1607997,
      "currentVolume": 823942
    },
    "derived": {
      "ma20": 398.1935,
      "ma50": 397.503,
      "prevClose": 385.73,
      "avgVolume10": 1506524,
      "avgVolume20": 1607997,
      "changePercent": -2.53,
      "avgVolumeForScore": 1607997
    },
    "ma_cross": {
      "ma20": 398.1935,
      "ma50": 397.503,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 398.731,
      "prevMa50": 397.837,
      "spreadPct": 0.17,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 359.6329,
      "upper": 436.7541,
      "position": "中間"
    },
    "rsi_short": 23.99,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.51
    }
  }
}

{
  "close": 375.98,
  "volume": 823942,
  "changePercent": -2.53
}